# Screening for Albuminuria at the First Line for Early Identification of CKD

> **NCT05321095** · — · COMPLETED · sponsor: **General Practitioners Research Institute** · enrollment: 141 (actual)

## Conditions studied

- Chronic Kidney Diseases
- Albuminuria

## Interventions

- **DIAGNOSTIC_TEST:** Albuminuria test
- **DIAGNOSTIC_TEST:** HbA1c test
- **DIAGNOSTIC_TEST:** Creatinine test

## Key facts

- **NCT ID:** NCT05321095
- **Lead sponsor:** General Practitioners Research Institute
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-25
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-07-30
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2024-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05321095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05321095, "Screening for Albuminuria at the First Line for Early Identification of CKD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05321095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*